Advertisements

Histacort Cream

Quick links to important sections

Histacort Cream

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Histacort Cream

Quick Facts Overview

Property Description
Active Ingredient Prednisolone
Form Cream (Topical)
Pharmacological Class Corticosteroid (Glucocorticoid)
General Purpose Reducing inflammation and itching
Origin Synthetic

What is Histacort Cream, and What Type of Medicine is It?

Histacort Cream is a medication intended for application on the skin, categorized as a topical anti-inflammatory and anti-allergic agent. Its active ingredient is Prednisolone, a substance which is classified within the corticosteroid class of medicines, specifically glucocorticoids. Corticosteroids are powerful anti-inflammatory medicines. The active ingredient is a synthetic compound, and the product is defined as a single-ingredient topical formulation.

Corticosteroids are distinct from simple moisturizing creams. Prednisolone is clinically recognized for its rapid onset of action in suppressing the severe redness, swelling, and persistent inflammation that accompany various skin conditions, offering significant relief from irritation.


Understanding the Form and Composition

Histacort is formulated as a cream, which is a topical dosage form defined as an emulsion—a light base combining oil and water. This cream base is intended for topical administration, allowing for relatively easy and quick absorption into the outer layers of the skin. Topical glucocorticoids are highly effective for many inflammatory dermatoses.

The cream base is a key distinguishing feature of Histacort, making it generally less greasy and more comfortable for use on moist or larger areas of skin, compared to heavier ointment forms of Prednisolone. The cream also contains various inactive ingredients that contribute to a comfortable and absorbent vehicle.


What is the General Purpose of Histacort Cream?

The core purpose of Histacort Cream is to reduce and relieve the uncomfortable symptoms of skin inflammation, redness, and intense itching. It achieves this by calming the localized defense signals that the body releases in response to irritation. By significantly minimizing the inflammatory process, the cream helps to suppress the associated swelling and irritation, bringing inflamed skin back to a more normal, soothed state.

Regulatory References

  1. Topical Corticosteroids (NIH/StatPearls)
  2. Topical Corticosteroids (NIH/StatPearls)
Advertisements

What side effects are possible with Histacort Cream?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety information for Histacort Cream, strictly based on government regulatory guidance. This medicine's safety profile is categorized based on whether effects are localized to the application site or result from systemic absorption.

Adverse Reactions

Type of Reaction Examples (Not a complete list)
Local Skin Reactions Burning, itching, irritation, dryness, skin atrophy, folliculitis, striae, and hypopigmentation. These are generally the most frequent reactions.
Systemic Reactions Potential for reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria. These are considered rare but serious risks associated with absorption.

Safety Considerations

Official regulatory documents note that the risk of systemic adverse reactions is increased by certain factors. These conditions include:

  • Exposure: Using the cream over large surface areas, for prolonged periods, or with occlusive dressings enhances the potential for absorption.
  • Population: Pediatric patients are more susceptible to systemic toxicity and HPA axis suppression due to their proportionally larger skin surface area-to-body weight ratio.

Restrictions and Limitations

Histacort Cream is contraindicated for use in patients with a history of hypersensitivity to any of its components. Caution is advised to avoid contact with the eyes due to the risk of conditions like glaucoma. The use of the cream should be restricted or carefully considered in the presence of certain untreated skin infections (bacterial, fungal, viral) or skin ulcers, as documented in regulatory guidelines.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The primary concern regarding an overdose of Histacort Cream (which contains prednisolone) relates to the systemic absorption of the corticosteroid following excessive or prolonged application, rather than a single topical event. This risk is heightened when the cream is used on large surface areas, for long periods of time, under occlusive dressings, or when applied to infants and children.

Over-application can lead to the systemic effects associated with prolonged corticosteroid exposure, including reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the development of clinical signs resembling Cushing's syndrome. Other documented systemic manifestations may include hyperglycemia and glycosuria.

Emergency Medical Action

The most serious acute overdose scenario is the accidental swallowing of the cream. In this event, or in any case of suspected overdose or systemic reaction, immediate medical help must be sought.

The absence of immediate or severe symptoms does not rule out the possibility of systemic effects. If HPA axis suppression is confirmed through appropriate medical testing, a healthcare provider will typically initiate a plan to gradually withdraw the medication or reduce the frequency of application to reverse the condition.

Advertisements

Therapeutic Uses of Histacort Cream

This section outlines the primary therapeutic uses and patient-oriented benefits of Histacort Cream.

This type of topical treatment is commonly used to help manage symptoms related to inflammatory or irritative states. Histacort Cream is applied across domains where additional symptomatic support is needed, and is relevant in contexts involving heightened systemic burden.


Managing Acute Symptoms and Localized Discomfort

The cream is often used when symptoms associated with acute or episodic changes become more disruptive during flare-ups. It helps address symptom clusters that may become intense or disruptive, offering supportive relief during phases when symptoms become more noticeable and create noticeable physiological strain. This may be part of symptomatic management in situations involving certain distressing symptoms.


Supporting Functional Stability During Symptomatic Periods

Histacort Cream is applicable within clinical settings that involve acute or unstable symptom patterns, and is used across conditions where functional stability becomes affected. It is relevant for managing symptoms that interfere with daily comfort, and provides support that helps ease the overall symptom burden. It assists with maintaining functional stability and supports patients during episodes of heightened discomfort.


Quick Fact: Relief for Inflammatory Symptoms

Histacort Cream is generally used for conditions characterized by periods of heightened symptoms, helping to improve day-to-day comfort during symptomatic periods.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Histacort Cream?

Eligibility for Histacort Cream (Prednisolone Topical) is determined by regulatory guidance, primarily based on the patient's age and the condition of the skin at the application site.

Contraindications: Who Must Not Use

Histacort Cream is strictly contraindicated for use in the following populations and conditions:

  • Infants and Children Under 1 Year of Age.
  • Patients with known hypersensitivity to Prednisolone or the cream's components.
  • Application on skin affected by untreated infections (viral, bacterial, fungal, or parasitic).
  • Skin conditions such as rosacea, perioral dermatitis, or acne vulgaris.
  • Skin lesions caused by viruses (e.g., herpes simplex, chickenpox) or tuberculosis.

Restricted and Conditional Use

Certain groups may use the cream only under specific limitations due to increased systemic risk:

Population Regulatory Restriction
Children over 1 year Use must be limited to the shortest duration and lowest effective dose.
Pregnant Patients Use is conditional; avoid extensive use or prolonged periods.
Breastfeeding Patients Use is conditional; avoid application to the breast area to prevent infant ingestion.

Standard use is generally permitted for adults who do not have any of the listed contraindications.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Histacort Cream based on the systemic absorption risk of its active ingredient, Prednisolone, focusing on pharmacokinetic and pharmacodynamic interactions.

Pharmacokinetic Interactions

Interacting Substance Class Official Interaction Description
CYP3A4 Inhibitors (e.g., Ritonavir, Cobicistat) Co-administration is documented to decrease the clearance of the corticosteroid, leading to significantly increased systemic exposure and potential for systemic effects, such as adrenal suppression.
CYP3A4 Inducers (e.g., Rifampicin, Phenytoin) Co-administration is documented to increase the clearance of the corticosteroid, which may reduce its overall systemic effect.

Pharmacodynamic and Population-Based Interactions

Official documentation notes potential for pharmacodynamic effects with co-administered medicines, particularly where the topical application results in significant systemic absorption. Concurrent use with Antidiabetic Agents may oppose their action by increasing blood glucose concentrations. Administration with NSAIDs or salicylates is documented to increase the official risk of gastrointestinal side effects. Furthermore, an enhanced effect of the corticosteroid is officially noted in patients with underlying conditions such as cirrhosis (hepatic impairment) and hypothyroidism due to impaired elimination.

Advertisements

Mechanism of Action

Genomic Regulation and the Glucocorticoid Receptor

Prednisolone, the active ingredient, acts via a genomic mechanism by operating as an agonist for the intracellular Glucocorticoid Receptor (GR). The binding facilitates the entry of the drug-receptor complex into the cell nucleus, where it modifies gene expression. This dual action involves transrepression, which switches off the transcription of numerous pro-inflammatory proteins (like cytokines and chemokines), and transactivation, which promotes the synthesis of anti-inflammatory mediators. This mechanism effects a widespread modulation of the inflammatory signal cascade.


Enzymatic Blockade and Cellular Dynamics

A key outcome of this genomic action is the induction of the protein Annexin A1, which in turn inhibits the enzyme Phospholipase A2 (PLA2). By blocking PLA2, the cream prevents the release of the precursor material required to synthesize key signaling molecules that initiate tissue response, specifically Prostaglandins and Leukotrienes. Physiologically, this mechanism works to reverse the excessive capillary permeability and suppress the migration of immune cells (leukocytes) from the blood vessels into the skin tissue, which limits localized fluid accumulation (edema) and suppresses the sustained cellular activity that maintains the tissue response.

Advertisements

Dosage and Administration Information

Histacort Cream is administered via the topical route and is strictly for external cutaneous application. The application method involves dispensing a thin film of the cream and rubbing it gently into the affected area until it disappears. The appropriate quantity is often determined using the Fingertip Unit (FTU) method, a standard clinical measurement where one FTU is approximately 0.5 g for adults and is used to estimate coverage for specific body areas.

The standard application schedule is typically once daily (OD) or twice daily (BID), as once-daily application may be sufficient for many conditions. Treatment follows a short-term course and is intended to be discontinued promptly when disease control is achieved. While continuous courses may extend up to 12 weeks for medium-potency formulations, use must not exceed the prescribed duration.

For children 1 year of age and older, usage should be restricted to the minimum effective amount and shortest duration, with continuous application often not exceeding 3 weeks for related agents. Use in children under 1 year of age is generally not recommended. The cream should not be used with occlusive dressings (e.g., tight bandages or plastic wrap) unless otherwise specifically directed. To prevent dilution and maintain intended effect, an interval of approximately 30 minutes is advised between applying the cream and concurrent emollients or moisturizers.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Histacort Cream

The active ingredient in Histacort Cream, a topical corticosteroid, has been widely studied in clinical research, primarily focusing on how symptoms change over time in common inflammatory skin conditions. The evidence base consists of many well-designed trials and systematic reviews that help establish what has been observed so far and what aspects remain uncertain.


Evidence for Use in Corticosteroid-Responsive Skin Inflammation

Research has focused on understanding how this class of medicine was evaluated in conditions where the skin shows redness, inflammation, and persistent itching. These studies were mostly designed as short-term Randomized Controlled Trials (RCTs), where a group using the active cream was compared against a group using an inactive vehicle or placebo cream.

Understanding the Research for Acute Inflammatory Symptoms

Studies were conducted during periods of increased symptom activity, exploring how symptoms change over time. Researchers monitored outcomes related to physical discomfort, such as the overall change in visible signs (often using standardized clinical assessment scores) and patient-reported outcomes describing perceived discomfort, like the intensity of itching. Findings describe patterns observed in the studies that showed measured changes in clinical signs over the short treatment intervals. However, the evidence is often general to the entire class of topical steroids; the specific findings for the prednisolone formulation require caution as results apply only to the populations studied.


Evidence for Use in Atopic Dermatitis (Eczema)

Atopic Dermatitis (Eczema) is the condition that has been most extensively evaluated, providing the highest volume of available data. The evidence base here is composed of numerous systematic reviews and meta-analyses combining the data from clinical trials. Research examined how symptoms evolved in the observed populations, particularly for conditions characterized by fluctuating or episodic manifestations.

Comparative Studies and Evidence Quality

Studies explored the patterns related to this medicine class during episodes where symptoms become more noticeable. Researchers monitored specific objective measures of skin inflammation, like the Eczema Area and Severity Index (EASI) and patient-reported outcomes capturing phases of heightened symptom activity, such as sleep disturbance due to itch. Systematic reviews reported that measured outcomes were observed in some studies more frequently with the active cream when compared to the placebo cream. Evidence contributes to understanding symptom patterns, but evidence quality varies across studies for direct comparison of every formulation.

Key Studies & References Topical Corticosteroids - StatPearls - NCBI Bookshelf (General Efficacy and Indications)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Histacort Cream (FAQ)

Q: How quickly does Histacort Cream typically start to reduce itching or redness?

A: Official product information describes the active ingredient, Prednisolone, as having a rapid onset of action in calming inflammation and redness. While specific timelines for individual patient relief are not provided, clinical studies focusing on this type of medicine often monitor outcomes measured over days or a few weeks of short-term use.

Q: What are the possible long-term effects of using Histacort Cream?

A: Regulatory documents indicate that the risk of adverse effects is noted to increase with prolonged use beyond the recommended duration. Potential systemic effects associated with absorption include HPA axis suppression and manifestations of Cushing's syndrome. Thinning of the skin (atrophy) is also a potential local effect.

Q: What happens if I use Histacort Cream more often than is recommended?

A: Applying the cream more often than the recommended schedule, or covering a large skin area with it, can significantly increase the systemic absorption of the active ingredient. This enhanced absorption raises the potential for systemic adverse effects, such as the suppression of the body's natural hormone production (HPA axis suppression).

Q: Is it possible to become dependent on Histacort Cream?

A: Government regulatory bodies have reviewed reports of a condition described by patients as Topical Steroid Withdrawal (TSW) reactions following the prolonged and continuous use of topical corticosteroids. Symptoms noted in these reports, which occur after stopping the cream, can include intense redness and a burning sensation.

Q: What is Topical Steroid Withdrawal (TSW) and is it a risk with Histacort Cream?

A: Topical Steroid Withdrawal (TSW) is a term used by patients for severe reactions reported after discontinuing topical corticosteroids that were used for prolonged periods. Regulatory reviews have assessed these reports, noting that symptoms can include an intense burning sensation and severe redness that may appear worse than the original condition.

Q: What is the difference between a cream and an ointment formulation of this medicine?

A: A cream is defined as an emulsion (a mix of oil and water) that is generally less greasy and easier to absorb, making it suitable for moist or large skin areas. An ointment is typically oil-based, providing a heavier, more occlusive layer that is often preferred for very dry, thick, or scaly skin, and is noted to potentially enhance absorption.

Q: What does it mean if the rash comes back right after I stop using Histacort Cream?

A: Official guidance notes that a rebound exacerbation of the treated condition may occur when topical corticosteroids are discontinued. This means the original symptoms, such as the rash, may return or become worse after stopping the medicine. Rebound is discussed in official contexts as distinct from a Topical Steroid Withdrawal reaction.

Q: Is Histacort Cream a cure for the condition it treats?

A: No. Official sources describe topical corticosteroids as medications that are not curative for the underlying condition. Their primary purpose is to quickly reduce inflammation and relieve the uncomfortable symptoms associated with inflammatory skin conditions.

Q: Can Histacort Cream change my skin color (cause lightening or darkening)?

A: Hypopigmentation, which is the lightening of the skin color, is an officially documented local skin reaction associated with the use of topical corticosteroids.

Q: Is Histacort Cream considered a non-steroidal treatment?

A: No. Histacort Cream is not a non-steroidal treatment. Its active ingredient, Prednisolone, is classified in official documents as a corticosteroid, specifically falling under the glucocorticoid class of medicines.

Q: What cautions are advised regarding Histacort Cream use in patients with diabetes or glaucoma?

A: Regulatory documents advise caution for patients with a pre-existing risk for glaucoma and for patients using Antidiabetic Agents. This is because systemic absorption of the corticosteroid may raise blood glucose concentrations, and contact with the eye must be strictly avoided due to potential risks like glaucoma.

Q: Does the cream lose its effectiveness if used for a long time?

A: Clinical research has noted that continued treatment with topical corticosteroids may be associated with a decreased response over time, a phenomenon known as tachyphylaxis. This suggests a potential for the tissue to become less responsive to the drug's anti-inflammatory effects over time.

Q: Are there different strengths of Histacort Cream?

A: Regulatory agencies classify all topical corticosteroids by their strength (potency) into four categories: Mild, Moderate, Strong, or Very Strong. Topical prednisolone formulations generally fall within the mild to moderate potency class, depending on the specific concentration and base.

Q: What type of research has been conducted on Histacort Cream?

A: The evidence base for this class of medicine primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews focusing on how symptoms change over time. These studies may also use a method called the vasoconstrictor assay (skin blanching) to assess product similarity and absorption.

Q: Will Histacort Cream affect the results of a skin patch test?

A: Official guidelines used in a clinical setting generally note that topical corticosteroid creams should be avoided on the testing area for a period of time prior to a skin patch test. This is because the strong anti-inflammatory effect could potentially suppress the reaction needed for the test results.

Q: Can I use Histacort Cream on my scalp or other hairy areas?

A: Official guidance notes that the cream formulation is intended for relatively easy absorption. While there are no explicit contraindications for hairy areas, other formulations, like lotions or foams, may be favored in clinical practice for very hairy areas like the scalp.

Q: Can men use Histacort Cream for conditions in the genital area?

A: Regulatory guidance advises that application to areas of thinner skin, such as the groin or genitals, may increase the potential for adverse effects due to higher systemic absorption. For this reason, use in these sensitive areas should be limited to the shortest possible duration.

Q: What is the shelf life of Histacort Cream after I open the tube?

A: While the manufacturer's expiry date applies to unopened containers, general practice guidance for topical preparations in tubes often advises using and disposing of the product within three months of opening. Specific manufacturer instructions should be followed if available.

Q: Are there any food or drink interactions with topical Histacort Cream?

A: Official regulatory documentation for topical prednisolone formulations does not list any known interactions with specific foods or drinks.

Q: Does Histacort Cream help with scarring or only with inflammation?

A: The official general purpose of Histacort Cream is to reduce and relieve the uncomfortable symptoms of skin inflammation, redness, and itching. It is not typically cited in regulatory documents for the purpose of treating or reducing scarring.

Q: How do different potency levels of topical steroids compare?

A: Topical steroids are classified by their strength (potency), generally into four main groups: Mild, Moderate, Strong, and Very Strong. Regulatory documentation notes that the risk of adverse effects, including skin thinning, generally increases with higher potency.

Q: How can I tell if the cream is working?

A: Evidence of the cream working in clinical studies relates to measured changes in visible signs of inflammation and patient-reported outcomes describing perceived discomfort. A reduction in the intensity of itching and the degree of redness are common indicators mentioned in research.

Q: Can Histacort Cream cause new hair growth or affect existing hair?

A: Hypertrichosis (excessive hair growth) is listed in official documents as a potential local adverse reaction associated with the use of topical corticosteroids.

Q: Can Histacort Cream cause a rebound flare when stopped?

A: Official information notes that a rebound of the treated skin condition or a Topical Steroid Withdrawal reaction may occur after the sudden discontinuation of topical corticosteroids, particularly following long-term, continuous use.

Q: What cautions are advised regarding Histacort Cream use in patients with high blood pressure?

A: Systemic side effects associated with topical corticosteroids, which are increased by prolonged or extensive use, may include hypertension (high blood pressure). Caution is advised when using the medicine, especially if there is a pre-existing risk of high blood pressure.

Q: Does the concentration percentage on the label mean the cream is stronger?

A: No. Regulatory agencies note that the labelled percentage concentration does not reliably indicate the cream's strength. The cream's true strength is determined by the specific corticosteroid molecule and its formulation, classified as Mild, Moderate, Strong, or Very Strong.

Q: Why are there different application techniques (like the fingertip unit)?

A: The Fingertip Unit (FTU) is a standardized clinical measurement used to help estimate the appropriate quantity of cream needed to treat a specific body area. This technique is designed to prevent overuse, which is cited in regulatory documents as a factor that can increase the risk of systemic adverse effects.

Q: What are the risks of Histacort Cream absorption in children?

A: Official documents indicate that pediatric patients are more susceptible to systemic toxicity and HPA axis suppression. This increased risk is due to their proportionally larger skin surface area-to-body weight ratio, which leads to greater potential absorption.

Q: Is Histacort Cream effective for acne or rosacea?

A: No. Official regulatory documents list both acne vulgaris and rosacea as contraindications for the use of Histacort Cream. This means the cream must not be applied to skin affected by these conditions.

Advertisements

How should Histacort Cream be stored and disposed of?

Histacort Cream (Prednisolone/Hydrocortisone Cream) must be stored and disposed of according to specific government-mandated requirements to ensure stability and safety.


Storage and Handling

The cream requires storage at Controlled Room Temperature, typically 20^circ to 25 C (68^circ to 77 F), and must be protected from freezing and excessive heat. The container should be kept tightly closed and stored away from bright light and moisture. As a mandatory safety measure, the product must be stored out of the sight and reach of children.


Disposal Instructions

Official regulatory guidelines instruct against flushing the cream down the toilet or throwing it in household trash. Unused or expired medication should be taken to a drug take-back program or returned to a pharmacy for safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Histacort Cream found in:

A-Z Index: